Carballido, J <br/><br/>
[Economic evaluation of medical treatment of benign prostatic hyperplasia (BPH) in the specialised care setting in Spain. Application to the cost-effectiveness of two drugs frequently used in its treatment].  [electronic resource] 

 -  Actas urologicas espanolas  Oct 2008 
 - 916-25 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0210-4806 
<br/><br/><label>Standard No.: </label>10.1016/s0210-4806(08)73960-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic alpha-Antagonists--economics<br/>Aged<br/>Aged, 80 and over<br/>Cost-Benefit Analysis<br/>Double-Blind Method<br/>Humans<br/>Male<br/>Middle Aged<br/>Plant Extracts--economics<br/>Prostatic Hyperplasia--drug therapy<br/>Serenoa<br/>Spain<br/>Sulfonamides--economics<br/>Tamsulosin